JOURNAL ARTICLE
Simultaneous Treatment of COVID-19 With Serine Protease Inhibitor Camostat and/or Cathepsin L Inhibitor?
Stefan BittmannAnne WeissensteinGloria VillalonElena Moschüring-AlievaElisabeth Luchter
Year: 2020 Journal: Journal of Clinical Medicine Research Vol: 12 (5)Pages: 320-322 Publisher: Elmer Press Inc.
Keywords:
Serine protease Medicine Protease inhibitor (pharmacology) Proteinase inhibitor Pharmacology Coronavirus disease 2019 (COVID-19) Virology Protease Biochemistry Enzyme Internal medicine Chemistry Human immunodeficiency virus (HIV) Viral load Antiretroviral therapy
Metrics
32
Cited By
0.89
FWCI (Field Weighted Citation Impact)
11
Refs
0.84
Citation Normalized Percentile
Is in top 1%
Is in top 10%
Citation History
Topics
COVID-19 Clinical Research Studies
Health Sciences → Medicine → Infectious Diseases
SARS-CoV-2 and COVID-19 Research
Health Sciences → Medicine → Infectious Diseases
Retinal and Optic Conditions
Health Sciences → Medicine → Ophthalmology
Related Documents
JOURNAL ARTICLE
COVID 19: Camostat and The Role of Serine Protease Entry Inhibitor TMPRSS2
Journal: Journal of Regenerative Biology and Medicine Year: 2020
JOURNAL ARTICLE
Treatment of Ulcerative Colitis with Camostat Mesilate, A Serine Protease Inhibitor.
S. SendaYoshihide FujiyamaTadao BambaShiro Hosoda
Journal: Internal Medicine Year: 1993 Vol: 32 (4)Pages: 350-354
BOOK-CHAPTER
Plant Serine Protease Inhibitor
xPharm: The Comprehensive Pharmacology Reference Year: 2007 Pages: 1-1